Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Berstein

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
Cancer|June 1, 2007
Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancerVladimir F Semiglazov, Vladislav V Semiglazov, Garik A Dashyan, et al.
International Journal of Cancer|April 3, 2007
Signs of proinflammatory/genotoxic switch (adipogenotoxicosis) in mammary fat of breast cancer patients: role of menopausal status, estrogens and hyperglycemiaLev M Berstein, Anatolij Y Kovalevskij, Tatjana E Poroshina, et al.
Cancer Letters|April 10, 2004
CYP17 and CYP19 genetic polymorphisms in endometrial cancer: association with intratumoral aromatase activityLev M Berstein, Evgeny N Imyanitov, Anatolij Ju Kovalevskij, et al.
Journal of Cancer Research and Clinical Oncology|February 24, 2001
CYP19 gene polymorphism in endometrial cancer patientsL M Berstein, E N Imyanitov, E N Suspitsin, et al.
Cell Cycle (Georgetown, Tex.)|August 30, 2008
Metformin slows down aging and extends life span of female SHR miceVladimir N Anisimov, Lev M Berstein, Peter A Egormin, et al.
International Journal of Cancer|December 10, 2002
Evidence against involvement of p53 polymorphism in breast cancer predispositionEvgeny N Suspitsin, Konstantin G Buslov, Maxim Yu Grigoriev, et al.
Cancer Letters|March 26, 2002
CYP17 genetic polymorphism in endometrial cancer: are only steroids involved?Lev M Berstein, Evgeny N Imyanitov, Vera B Gamajunova, et al.
Aging|March 10, 2011
If started early in life, metformin treatment increases life span and postpones tumors in female SHR miceVladimir N Anisimov, Lev M Berstein, Irina G Popovich, et al.
Experimental Gerontology|August 30, 2005
Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic miceVladimir N Anisimov, Lev M Berstein, Peter A Egormin, et al.
Journal of Cancer Research and Clinical Oncology|April 16, 2003
Tumor estrogen content and clinico-morphological and endocrine features of endometrial cancerL M Berstein, A E Tchernobrovkina, V B Gamajunova, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
Cancer|June 1, 2007
Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancerVladimir F Semiglazov, Vladislav V Semiglazov, Garik A Dashyan, et al.
International Journal of Cancer|April 3, 2007
Signs of proinflammatory/genotoxic switch (adipogenotoxicosis) in mammary fat of breast cancer patients: role of menopausal status, estrogens and hyperglycemiaLev M Berstein, Anatolij Y Kovalevskij, Tatjana E Poroshina, et al.
Cancer Letters|April 10, 2004
CYP17 and CYP19 genetic polymorphisms in endometrial cancer: association with intratumoral aromatase activityLev M Berstein, Evgeny N Imyanitov, Anatolij Ju Kovalevskij, et al.
Journal of Cancer Research and Clinical Oncology|February 24, 2001
CYP19 gene polymorphism in endometrial cancer patientsL M Berstein, E N Imyanitov, E N Suspitsin, et al.
Cell Cycle (Georgetown, Tex.)|August 30, 2008
Metformin slows down aging and extends life span of female SHR miceVladimir N Anisimov, Lev M Berstein, Peter A Egormin, et al.
International Journal of Cancer|December 10, 2002
Evidence against involvement of p53 polymorphism in breast cancer predispositionEvgeny N Suspitsin, Konstantin G Buslov, Maxim Yu Grigoriev, et al.
Cancer Letters|March 26, 2002
CYP17 genetic polymorphism in endometrial cancer: are only steroids involved?Lev M Berstein, Evgeny N Imyanitov, Vera B Gamajunova, et al.
Aging|March 10, 2011
If started early in life, metformin treatment increases life span and postpones tumors in female SHR miceVladimir N Anisimov, Lev M Berstein, Irina G Popovich, et al.
Experimental Gerontology|August 30, 2005
Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic miceVladimir N Anisimov, Lev M Berstein, Peter A Egormin, et al.
Journal of Cancer Research and Clinical Oncology|April 16, 2003
Tumor estrogen content and clinico-morphological and endocrine features of endometrial cancerL M Berstein, A E Tchernobrovkina, V B Gamajunova, et al.
Pageof 14